Loading…
Vanda Pharmaceuticals Inc. is projected to rise to $5.55 by 2027, a +9% move from its current price of $5.10. VNDA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $4.99 | $5.10 | $5.21 | +0.01% |
| Aug 4 | $4.95 | $5.10 | $5.26 | +0.02% |
| Aug 5 | $4.92 | $5.10 | $5.29 | +0.03% |
| Aug 6 | $4.89 | $5.10 | $5.32 | +0.03% |
| Aug 7 | $4.86 | $5.10 | $5.35 | +0.04% |
| Aug 8 | $4.84 | $5.10 | $5.38 | +0.05% |
| Aug 9 | $4.82 | $5.10 | $5.40 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.82 | $5.10 | $5.40 | +0.06% |
| Week 2 | $4.71 | $5.11 | $5.53 | +0.12% |
| Week 3 | $4.63 | $5.11 | $5.63 | +0.18% |
| Week 4 | $4.57 | $5.11 | $5.72 | +0.24% |
| Week 5 | $4.51 | $5.12 | $5.80 | +0.30% |
| Week 6 | $4.46 | $5.12 | $5.88 | +0.36% |
| Week 7 | $4.41 | $5.12 | $5.95 | +0.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to address high unmet medical needs worldwide.
Its commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion. The company was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
VNDA trades at $5.05 per share. It has a market cap of $303.68M and is ranked 3474.
The near-term price outlook is broadly neutral, with a path that stays around current levels through 2029. From 2030 onward, the forecast projects a bullish trajectory, with the 2030 average price around $6.11 and continuing to rise to $11.32 by 2040 and $22.26 by 2050, while maximums reach $8.52 in 2030, $17.91 in 2040, and $38.03 in 2050.
A major floor 20.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.0% away) — a key level to hold.
The nearest ceiling, 29.0% above — a clean break opens room to run.
A major ceiling 48.2% above — clearing it would confirm fresh momentum.
Key VNDA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VNDA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.14 | Sell | $5.16 | Sell |
| MA 10 | $5.24 | Sell | $5.28 | Sell |
| MA 20 | $5.64 | Sell | $5.50 | Sell |
| MA 50 | $5.91 | Sell | $5.90 | Sell |
| MA 100 | $6.57 | Sell | $6.23 | Sell |
| MA 200 | $6.52 | Sell | $6.23 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.43 | Neutral |
| Stoch RSI (14) | 31.36 | Neutral |
| CCI (20) | -81.97 | Neutral |
| Williams %R (14) | -93.75 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -12.82 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 6.25 | Buy |
| TRIX (15) | -0.53 | Sell |
| Awesome (5,34) | -0.63 | Sell |
| Ultimate (7,14,28) | 28.16 | Buy |
| Momentum (10) | -0.34 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 5.07 | Buy |
| ADX (14) | 25.19 | Sell |
| ATR (14) | 0.12 | Info |
30-day technical picture is NEUTRAL. RSI14 is 30, indicating oversold conditions.
The stock trades below the SMA50 of $5.95 and the SMA200 of $6.53, with the current price at $5.05, placing it near support at $5.05 and resistance at $6.58. The 30-day range runs from $4.37 to $5.83, highlighting a tight trading band ahead of the next move.
Overall, volatility is observable with an annualized volatility of 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.05 | $5.10 | $6.40 | 0% | Neutral | |
| $4.52 | $5.55 | $7.16 | +9% | Neutral | |
| $4.59 | $5.77 | $7.67 | +13% | Neutral | |
| $4.57 | $5.84 | $7.95 | +15% | Neutral | |
| $5.09 | $6.61 | $9.18 | +30% | Bullish | |
| $5.75 | $7.58 | $10.71 | +49% | Bullish | |
| $6.28 | $8.38 | $12.03 | +64% | Bullish | |
| $6.54 | $8.83 | $12.86 | +73% | Bullish | |
| $6.16 | $8.41 | $12.41 | +65% | Bullish | |
| $6.58 | $9.09 | $13.58 | +78% | Bullish | |
| $8.85 | $12.84 | $20.20 | +152% | Bullish | |
| $16.40 | $25.83 | $43.86 | +407% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.05 | $5.10 | $6.14 | +0.00% |
| September 2026 | $4.45 | $5.23 | $6.30 | +2.64% |
| October 2026 | $4.35 | $5.14 | $6.24 | -1.80% |
| November 2026 | $4.28 | $5.07 | $6.20 | -1.29% |
| December 2026 | $4.37 | $5.20 | $6.40 | +2.53% |
Click any year to see its month-by-month VNDA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, VNDA is projected to trade between $5.05 and $6.40, averaging $5.10 — a potential gain of 0% from today's $5.10. Price action looks broadly range-bound.
Vanda Pharmaceuticals Inc.'s 2027 outlook centres on $5.55, within a $4.52 to $7.16 range. That is up +9% on the projected 2026 average. That marks a +9% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, VNDA could reach as high as $7.67, with a base case around $5.77 and support toward $4.59 — roughly +13% from $5.10. Price action looks broadly range-bound.
Expect VNDA to range from $4.57 to $7.95 through 2029. The $5.84 average target implies a +15% move from current prices. That is up +1% on the projected 2028 average. A consolidation phase looks the most probable path here.
The VNDA price prediction for 2030 points to an average of $6.61 (low $5.09, high $9.18) — a potential gain of +30% on today's $5.10. Momentum favours further upside here.
In 2031, VNDA is projected to trade between $5.75 and $10.71, averaging $7.58 — a potential gain of +49% from today's $5.10. That is up +15% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Vanda Pharmaceuticals Inc.'s 2032 outlook centres on $8.38, within a $6.28 to $12.03 range. That is up +11% on the projected 2031 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2033, VNDA could reach as high as $12.86, with a base case around $8.83 and support toward $6.54 — roughly +73% from $5.10. Buyers look set to stay in control over this stretch.
Expect VNDA to range from $6.16 to $12.41 through 2034. The $8.41 average target implies a +65% move from current prices. That is -5% versus the projected 2033 average. Momentum favours further upside here.
The VNDA price prediction for 2035 points to an average of $9.09 (low $6.58, high $13.58) — a potential gain of +78% on today's $5.10. Buyers look set to stay in control over this stretch.
In 2040, VNDA is projected to trade between $8.85 and $20.20, averaging $12.84 — a potential gain of +152% from today's $5.10. That is up +41% on the projected 2035 average. Momentum favours further upside here.
Vanda Pharmaceuticals Inc.'s 2050 outlook centres on $25.83, within a $16.40 to $43.86 range. That is up +101% on the projected 2040 average. That marks a +407% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in VNDA today (≈ 196.078431 VNDA) could be worth
$5,065.54
+$4,065.54 (+407%) by 2050 · US Dollar
Based on the average projected VNDA price of $25.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VNDAwould be worth at today's price.
$1,000 invested in VNDA on Jul 31, 2025 (≈ 234.741771 VNDA) would be worth
$1,197.18
+$197.18 (+19.7%) today · 1.20× · US Dollar
Based on a VNDA entry price of $4.26 vs. today's $5.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.18 | $984.56 | -1.5% |
| 1 month ago | $6.05 | $842.98 | -15.7% |
| 3 months ago | $7 | $728.57 | -27.1% |
| 6 months ago | $7.74 | $658.91 | -34.1% |
| 1 year ago | $4.26 | $1,197.18 | +19.7% |
| All time (5.0y) ago | $16.92 | $301.42 | -69.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VNDA forecast.
Our base-case forecast reaches $10.00 around 2040.
Implied market cap at $10.00: $601.36M
2030 onward shows a bullish trajectory with rising averages and upside potential. The 2030 forecast lists a min of $4.69, an avg of $6.11, and a max of $8.52, with a 21.1% ROI and a BULLISH sentiment.
2031 through 2035 continue the bullish trend: 2031 avg $6.98, max $9.91, ROI 38.3%; 2032 avg $7.71, max $11.12, ROI 52.8%; 2033 avg $8.04, max $11.77, ROI 59.3%; 2034 avg $7.64, max $11.33, ROI 51.4%; 2035 avg $8.20, max $12.31, ROI 62.4%.
Between 2040 and 2050 the forecast accelerates further: 2040 avg $11.32, max $17.91, ROI 124.2% with a BULLISH sentiment; 2050 avg $22.26, max $38.03, ROI 340.7% continuing the bullish outlook.
Tap a question to reveal the answer.
2030 min $4.69, avg $6.11, max $8.52; ROI 21.1%; sentiment BULLISH.
The forecast shows a neutral stance in 2026-2029, then a bullish path from 2030 onward, with the average price rising to $6.11 in 2030 and up to $22.26 by 2050, and a max of $38.03 in 2050. ROI reaches up to 340.7%. These are estimates, not guarantees.
Yes. The forecast lists a max of $38.03 by 2050, with higher long-term upside implied by the path to 2050 (avg $22.26; min $14.02 in some years not cited here). Note these are estimates, not guarantees.
Current price is $5.05; market cap is $303.68M.
Sentiment is NEUTRAL with RSI14 at 30. The price is $5.05, below the SMA50 of $5.95 and the SMA200 of $6.53, near support at $5.05 and resistance at $6.58. The 30-day range is $4.37–$5.83.
Vanda Pharmaceuticals Inc. Community Discussion
0Share your Vanda Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.